- Home
- CRMD vs RERE Comparison
CRMD vs RERE Comparison
Compare CRMD & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- RERE
- Stock Information
- Founded
- CRMD 2006
- RERE 2011
- Country
- CRMD United States
- RERE China
- Employees
- CRMD N/A
- RERE N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- RERE Other Specialty Stores
- Sector
- CRMD Health Care
- RERE Consumer Discretionary
- Exchange
- CRMD Nasdaq
- RERE Nasdaq
- Market Cap
- CRMD 576.4M
- RERE 527.7M
- IPO Year
- CRMD 2010
- RERE 2021
- Fundamental
- Price
- CRMD $8.57
- RERE $2.81
- Analyst Decision
- CRMD Strong Buy
- RERE
- Analyst Count
- CRMD 5
- RERE 0
- Target Price
- CRMD $15.80
- RERE N/A
- AVG Volume (30 Days)
- CRMD 945.5K
- RERE 1.8M
- Earning Date
- CRMD 10-30-2024
- RERE 11-20-2024
- Dividend Yield
- CRMD N/A
- RERE N/A
- EPS Growth
- CRMD N/A
- RERE N/A
- EPS
- CRMD N/A
- RERE N/A
- Revenue
- CRMD $12,262,234.00
- RERE $2,188,701,829.00
- Revenue This Year
- CRMD N/A
- RERE $28.08
- Revenue Next Year
- CRMD $277.75
- RERE $25.05
- P/E Ratio
- CRMD N/A
- RERE N/A
- Revenue Growth
- CRMD 41184.20
- RERE 27.16
- 52 Week Low
- CRMD $2.89
- RERE $1.01
- 52 Week High
- CRMD $13.85
- RERE $3.70
- Technical
- Relative Strength Index (RSI)
- CRMD 40.01
- RERE 45.39
- Support Level
- CRMD $8.00
- RERE $2.67
- Resistance Level
- CRMD $9.02
- RERE $3.15
- Average True Range (ATR)
- CRMD 0.51
- RERE 0.22
- MACD
- CRMD -0.07
- RERE -0.07
- Stochastic Oscillator
- CRMD 28.93
- RERE 13.11
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.